Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy
Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy
Recruiting · NCT05101551 · Registry updated 2026-04-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Phase 1 | 2026-04-22 | NCT05101551 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Gateway for Cancer Research | 32 |
| Norman J. Lacayo | 1 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Arkansas Children's Hospital | Little Rock | United States | 82 |
| Cincinnati Children's Hospital | Cincinnati | United States | 66 |
| City of Hope | Duarte | United States | 238 |
| Pennsylvania State University Hershey Medical Center | Hershey | United States | 1 |
| Phoenix Children's Hospital | Phoenix | United States | 95 |
| St. Jude Children's Research Hospital | Memphis | United States | 194 |
| Stanford University | Stanford | United States | 213 |
| University of Utah | Salt Lake City | United States | 72 |
| University of Wisconsin Carbone Cancer Center | Madison | United States | 58 |